Press release
Strong Growth Ahead: Diabetic Macular Edema (DME) Market Size To Grow At Arecord 4.4% Cagr By 2029
Diabetic Macular Edema (DME) Market Analysis
How Big Is the Diabetic Macular Edema (DME) Market Size Expected to Be by 2034?
There has been a consistent increase in the market size for Diabetic Macular Edema (DME) recently. Projected growth forecasts show a rise from $4.67 billion in 2024 to $4.89 billion in 2025, with a compound annual growth rate (CAGR) of 4.7%. The notable expansion during the historical period is linked to factors such as the increasing occurrence of diabetes, the growth in disorders related to edema, a surge in cases of diabetic eye diseases, a rise in the elderly population, and an increase in instances of blindness.
The market for diabetic macular edema (DME) is predicted to experience consistent expansion in the coming years, reaching a value of $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the forecast period could include improved access to healthcare, increased government funding for healthcare, heightened public awareness of diabetes-related complications, wider use of telemedicine for eye care, and the proliferation of specialized centers for diabetes-related eye care. Notable trends projected for this period include the development of anti-VEGF therapies, the increasing use of corticosteroid implants, enhancements in drug delivery systems, advances in retinal laser treatments, the rise of AI-powered diagnostic tools, and the trend towards minimally invasive surgical methods.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21169
What Are the Emerging Segments Within the Diabetic Macular Edema (DME) Market?
The diabetic macular edema (DME) market covered in this report is segmented -
1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention
2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage
3) By Patient Demographics: Adults, Elderly, Children
4) By Route Of Administration: Intravitreal Injection, Topical, Systemic
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies
2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids
3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation
4) By Surgical Intervention: Vitrectomy, Membrane Peeling
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21169&type=smp
What Long-Term Drivers Are Shaping Diabetic Macular Edema (DME) Market Trends?
The growth of the diabetic macular edema (DME) market is likely to be propelled by the rising incidence of diabetes. Various factors such as an inactive lifestyle, poor eating habits, escalating obesity levels, aging societies and genetic susceptibility contribute to the growing prevalence of diabetes. Diabetic macular edema is caused by diabetes due to the damage it inflicts on the retinal blood vessels, causing fluid leak into the macula leading to swelling. For instance, the US-based public health research institute, the Institute for Health Metrics and Evaluation, reported in June 2023 that over half a billion people worldwide have diabetes. This number is set to more than double by 2050, increasing to 1.3 billion individuals. Consequently, the surging occurrence of diabetes is fueling the expansion of the diabetic macular edema (DME) market.
Who Are the Top Competitors in Key Diabetic Macular Edema (DME) Market Segments?
Major companies operating in the diabetic macular edema (DME) market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Carl Zeiss AG, Topcon Corporation, Ypsomed AG, ARKRAY Inc, Hugel Inc., Optos plc, Noven Pharmaceuticals Inc., Alimera Sciences Inc., Allergan plc.
What Trends Are Driving Growth in The Diabetic Macular Edema (DME) Market?
Leading businesses in the diabetic macular edema (DME) treatment sector are concentrating their efforts on hi-tech developments, including cutting-edge drug therapies, in their aim to enhance patient treatment and management. The use of innovative treatment options rooted in new technology and research, these advanced drug therapies aim to increase efficacy, lessen side effects, and provide superior results for those under their care. For example, in March 2022, Beovu received approval from the European Commission for the treatment of visual impairment due to diabetic macular edema (DME), announced by Novartis AG, a pharmaceutical corporation based in Switzerland. The endorsement hinged on the outcomes of Phase III KESTREL and KITE studies, which posited Beovu's effectiveness as similar to aflibercept in terms of visual improvement after a year. Impressively, more than half of the patients treated with Beovu adhered to a 12-week treatment schedule, experiencing less retinal fluid than those treated with aflibercept.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diabetic-macular-edema-dme-global-market-report
Which Regions Are Becoming Hubs for Diabetic Macular Edema (DME) Market Innovation?
North America was the largest region in the diabetic macular edema (DME) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic macular edema (DME) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diabetic Macular Edema (DME) Market?
2. What is the CAGR expected in the Diabetic Macular Edema (DME) Market?
3. What Are the Key Innovations Transforming the Diabetic Macular Edema (DME) Industry?
4. Which Region Is Leading the Diabetic Macular Edema (DME) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Diabetic Macular Edema (DME) Market Size To Grow At Arecord 4.4% Cagr By 2029 here
News-ID: 4069936 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for DME
Dimethyl Ether (DME) Production Cost
Dimethyl ether (DME) is a versatile chemical compound gaining increasing attention as a clean fuel, aerosol propellant, and intermediate for chemical synthesis. With properties similar to liquefied petroleum gas and favorable combustion characteristics, DME is widely explored for applications in transportation fuels, power generation, domestic energy use, and petrochemical processing. Understanding the production cost of dimethyl ether requires examining its feedstock pathways, process technologies, energy requirements, and regulatory obligations.
Request a…
Dimethyl Ether (DME) & R-DME Market Expansion and Future Trends | 2025 To 2034 O …
The Global Dimethyl Ether (DME) & R-DME Market Size, Scope, and Forecast 2025-2034 report is now part of Exactitude Consultancy's Market Research collection. Industry experts and researchers provide an authoritative and concise analysis of the Dimethyl Ether (DME) & R-DME Market, covering key aspects such as growth drivers, challenges, restraints, developments, and opportunities. This report delivers a precise evaluation of shifting market dynamics and emerging trends. Additionally, it offers a…
DME Service Solutions Partners with the AAHomecare
DME Service Solutions, a leader in providing B2B outsourcing solutions specializing in healthcare, is thrilled to announce its partnership with the American Association for Homecare (AAHomecare). This partnership allows DME Service Solutions to engage with a community dedicated to advancing quality care and operational efficiency in the homecare industry.
AAHomecare has served the home medical equipment (HME) industry for nearly four decades, advocating for improved access to quality homecare products…
Global Airport Ground DME Market Analysis (2020-2025)
Global Info Research offers a latest published report on Airport Ground DME Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Airport Ground DME Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure…
Global Durable Medical Equipment (DME) Market Insights, Forecast
Durable Medical Equipment (DME) is a medical equipment that durable, can be used in the home and have at least 3 years of life expectancy. The prevalence of chronic conditions, such as heart disorders, cancer, gynecological disorders, and neurological disorder is on a rise, demand of long term care and hospitalization for treatment of these disorders is anticipated to facilitate the demand for durable medical equipment. The global Durable Medical…
Durable Medical Equipment (DME) Global Market 2019
Press Release – 30 Jan 2019
Research and Development News --
. .
Latest Update "Global Durable Medical Equipment (DME) Market By Type, By Therapeutic and monitoring Devices Type, By End User, By Region, By Country (2018 Edition) - Forecast to 2023-By Type (Personal Mobility devices, Therapeutic and Monitoring Devices, Medical Furniture, Others), By Sub-Type (Oxygen Equipment, Blood Sugar Monitors, Continuous Passive Motions, Nebulizers, Other Devices), By End User (Hospitals and Clinics,…
